Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells—also known ...

Ancient DNA from Napoleon’s soldiers reveals enteric and relapsing fevers - not typhus - as key killers during the army’s ...

From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

From the telecoms side, Vodafone’s Darren Ennis called for a framework that is “future-proofed” and “fair”, stressing the ...

When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells - also known as "zombie cells" - stop dividing but don't die off as cells typically ...

SINGAPORE, Oct. 27, 2025 /PRNewswire/ — Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of ...

As enterprise AI company Uniphore raises $260 million from AI and data majors Nvidia, AMD, Snowflake, Databricks and other ...